Hans-Peter Gerber

Insider Reports History

Entity
Individual
Location
C/O Sutro Biopharma, Inc., 111 Oyster Point Boulevard, South San Francisco, CA
Signature
/s/ Edward C. Albini as attorney-in-fact for Hans-Peter Gerber
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hans-Peter Gerber:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SUTRO BIOPHARMA, INC. CHIEF SCIENTIFIC OFFICER Restricted Stock Units (RSUs) 113K $351K $3.12 Sep 18, 2024 Direct
SUTRO BIOPHARMA, INC. CHIEF SCIENTIFIC OFFICER Common Stock 24.1K $95.3K $3.95 Sep 18, 2024 Direct
SUTRO BIOPHARMA, INC. CHIEF SCIENTIFIC OFFICER Stock Option (Right to Buy Common Stock) 60K Mar 5, 2024 Direct

Insider Reports Filed by Hans-Peter Gerber

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STRO SUTRO BIOPHARMA, INC. Sep 18, 2024 3 -$52.9K 4 Sep 20, 2024 CHIEF SCIENTIFIC OFFICER
STRO SUTRO BIOPHARMA, INC. Mar 5, 2024 2 $0 4 Mar 7, 2024 CHIEF SCIENTIFIC OFFICER
STRO SUTRO BIOPHARMA, INC. Sep 18, 2023 2 $0 4 Sep 19, 2023 Chief Scientific Officer
STRO SUTRO BIOPHARMA, INC. Sep 18, 2023 0 $0 3 Sep 19, 2023 Chief Scientific Officer